By ...

12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

15 de May de 2026

The National Council for Advertising Self-Regulation (“CONAR”) released, last Monday (11), the new edition of the Guide to Marketing and Advertising by … CONAR updates Influencers Guide in line with the new requirements for transparency and protection in the digital environment

14 de July de 2025

The third edition of “Advertising Law: Year in Review”, featuring cases examined by CONAR in 2024, is now available! This publication, prepared … Third edition of “Advertising Law: Year in Review” is now available

5 de July de 2021

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges